A Randomized Controlled Trial Comparing Efficacy and Safety of Insulin Glargine 300 Units/mL Versus 100 Units/mL in Older People With Type 2 Diabetes: Results From the SENIOR Study.

R, Ritzel; SB, Harris; H, Baron; H, Florez; R, Roussel; M, Espinasse; I, Muehlen-Bartmer; N, Zhang; M, Bertolini; C, Brulle-Wohlhueter; M, Munshi; GB, Bolli

doi:10.2337/dc18-0168

Public

A Randomized Controlled Trial Comparing Efficacy and Safety of Insulin Glargine 300 Units/mL Versus 100 Units/mL in Older People With Type 2 Diabetes: Results From the SENIOR Study.

Shared by NobleBlocks on Jun 12, 2018 • 12:00 AM UTC

Authors:

Ritzel R

Harris SB

Baron H

Abstract

<h4>Objective</h4>SENIOR compared the efficacy and safety of insulin glargine 300 units/mL (Gla-300) with glargine 100 units/mL (Gla-100) in older people (≥65 years old) with type 2 diabetes.<h4>Research design and methods</h4>SENIOR was an open-label, two-arm, parallel-group, multicenter phase 3b t...

Discussions